Additional file 2 Outcomes reflecting care processes
Outcome
Definition
Feeding
=
Head of bed elevated at 30°
Adequate prevention of venous
thromboembolism
Rate of antibiotic use
When we assessed
How we assessed
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π ππππππ£πππ πππ‘ππππ ππ ππππππ‘ππππ πππππππ
πππ‘ππππ‘ − πππ¦π
Every 3 three days from ICU
day 2 to 17.
Checked prescription
=
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π π€ππ‘β βπππ ππ πππ ππππ£ππ‘ππ ππ‘ ≥ 30°
ππππππππ πππ‘ππππ‘ − πππ¦π
Every 3 three days from ICU
day 2 to 17.
Bed observation We considered
only patients with indication of
head of the bed at 30° (MV, enteral
feeding or altered level of
consciousness)
=
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π π€ππ‘β πππππ’ππ‘π π·ππ ππππ£πππ‘πππ
πππ‘ππππ‘ − πππ¦π
Every 3 three days from ICU
day 2 to 17.
Checked prescription
Every 3 three days from ICU
day 2 to 17.
Checked prescription
Adequate prevention of VTE is defined as: Dalteparin 5.000U 1x a day SC, enoxaparin
40mg 1x a day SC or heparin 5.000U 12/12hs SC or fondaparinux 2.5 mg 1x a day SC. A
higher dose can be used if the patient has indication of anticoagulation therapy. If
heparin is contraindicated: compression stockings ± pneumatic compression
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π π€ππ‘β πππ‘πππππ‘ππ ππππ πππππ‘πππ
=
X 100
πππ‘ππππ‘ − πππ¦π
=
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π π’ππππ πππππ’ππ‘π π ππππ‘πππ
πππ‘ππππ‘ − πππ¦π ππ ππ
Every 3 three days from ICU
day 2 to 17.
We assessed RASS of patients on
invasive mechanical ventilation
=
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π π€ππ‘β πππππππ ππ ππππ πππππ‘πππ
X 100
πππ‘ππππ‘ − πππ¦π
Every 3 three days from ICU
day 2 to 17.
Checked prescription
Tidal volume ≤ 8mL/kg of predicted
weight
=
πππ‘ππππ‘ − πππ¦π ππ ≤ 8ππΏ πππ πΎπ πππππππ‘ππ π€πππβπ‘
× 1000
πππ‘ππππ‘ − πππ¦π ππ ππ
Every 3 three days from ICU
day 2 to 17.
Checked mechanical ventilator
data
Central line-associated bloodstream
infection (CLABSI) rate
=
ππ’ππππ ππ πΆπΏπ΄π΅ππΌ
× 1000
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π π€ππ‘β ππππ‘πππ ππππ
Daily from ICU day 2 to 17.
Blood cultures and clinical data
Patients under adequate sedation
Patient-days under moderate, mild
sedation, or alert and calm (RASS -3 to 0)
Rate of analgesic use
Bloodstream infection defined according to the CDC criteria
Rate of ventilator-associated
pneumonia (VAP)
=
ππ’ππππ ππ ππ΄ππ
× 1000
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π ππ ππ
Daily from ICU day 2 to 17.
Laboratory and clinical data
Rate of urinary tract infection
associated with catheter (UTI)
=
ππ’ππππ ππ πππΌπ
× 1000
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π π€ππ‘β ππππ€ππππππ π’ππππππ¦ πππ‘βππ‘ππ
Daily from ICU day 2 to 17.
Urine culture and clinical data
Rate of mechanical ventilation
Rate of use of central line catheter
Rate of use of indwelling urinary
catheter
=
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π ππ ππ
× 100
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π
Daily from ICU day 2 to 17.
Patients’ inspection
=
ππ’ππππ ππ πΆππΆ − πππ¦
× 100
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π
Daily from ICU day 2 to 17.
Patients’ inspection
=
ππ’ππππ ππ πΌππΆ − πππ¦
π₯ 100
ππ’ππππ ππ πππ‘ππππ‘ − πππ¦π
Daily from ICU day 2 to 17.
Patients’ inspection